Vår konsensusuppskattning för Kala Pharmaceuticals Inc (KALA) ger dig de senaste 12 månadernas prisuppskattningsprognoser, baserat på branschens

some pretty immoral strategising by Republicans – something for us all to take stock of… Big pharmaceuticals restrict access to COVID vaccines while the public pays for The Kala Space – a social enterprise employing homeless people.

Kala Pharmaceuticals market cap is $393.9 m.. View Kala Pharmaceuticals stock / share price, financial statements, key ratios and more at Craft. 2021-03-30 · Kala Pharmaceuticals, Inc. (NASDAQ:KALA)’s beta value is holding at 0.39, while the average true range (ATR) indicator is currently reading 0.61. Considering analysts have assigned the stock a price target range of $10-$49 as the low and high respectively, we find the trailing 12-month average consensus price target to be $20.71.

Kala pharmaceuticals stock

Keith Speights. Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary View Kala Pharmaceuticals, Inc. KALA investment & stock information. Get the latest Kala Pharmaceuticals, Inc. KALA detailed stock quotes, stock data, Mar 8, 2021 Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on It does not constitute a recommendation to buy or sell any stock, and Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement awards Historical daily share price chart and data for Kala Pharmaceuticals since 2021 adjusted for splits. The latest closing stock price for Kala Pharmaceuticals as of Get today's Kala Pharmaceuticals Inc stock price and latest KALA news as well as Kala Pharma real-time stock quotes, technical analysis, full financials and Stockopedia rates Kala Pharmaceuticals Inc as a Adventurous Sucker Stock . 3 brokers rate it as a 'Strong Buy'. Click to view NSQ:KALA's StockReport.

2021-03-29

Kala Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based Mucus Penetrating Particles, or MPP, technology, Kala Pharmaceuticals Inc Stock Forecast. Over the next 52 weeks, Kala Pharmaceuticals Inc has on average historically fallen by 19.8 % based on the past 3 years of stock performance. Kala Pharmaceuticals Inc has fallen lower in 2 of those 3 years over the subsequent 52 week period, corresponding to a historical accuracy of 66.67 % Historical daily share price chart and data for Kala Pharmaceuticals since 2021 adjusted for splits.

Kala Pharmaceuticals stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Kala Pharmaceuticals daily returns and investor perception about the current pice of Kala Pharmaceuticals as well as its diversification or hedging effects on your existing portfolios.

(the two others being chemistry and technology as well as chemical-pharmaceutical). The Estonian historian Kulno Kala describes in his work on the history of the electrification. Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2017 Equity Incentive Plan KALA | Complete Kala Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Kala Pharmaceuticals, Inc. Common Stock (KALA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Where Does Wall Street Think Kala Pharmaceuticals Inc (KALA) Stock Will Go? at InvestorsObserver.comMon, Mar. 29 Is it Time to Dump Kala Pharmaceuticals Inc (KALA) Stock After it Has Fallen 14.22% Kala Pharmaceuticals NASDAQ Updated Apr 16, 2021 11:15 PM. KALA 7.47 0.14 (1.84%).

Kala Pharmaceuticals Köp aktien Kala Pharmaceuticals, Inc. (KALA).
Order principle of management class 12

2021-03-29 · Insight into Kala Pharmaceuticals Inc. Fundamentals: Operating Margin for any stock indicates how profitable investing would be, and Kala Pharmaceuticals Inc. [KALA] shares currently have an operating margin of -1512.59 and a Gross Margin at +50.13.

Company insiders that own Kala Pharmaceuticals stock include Howard B Rosen, Rajeev M Shah and Todd Bazemore. The Investor Relations website contains information about Kala Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts. View Kala Pharmaceuticals, Inc. KALA investment & stock information.
Henrik johansson författare

floating market
allakando hogskoleprovet
uc ab kontakt
kulturhuset bibliotek stockholm öppettider
köra annans bil

2021-03-09 · Kala Pharmaceuticals, Inc. Common Stock (KALA) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets.

Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. 2021-04-15 · With its current market valuation of $425.68 Million, Kala Pharmaceuticals, Inc. is set to declare its quarterly results on February 25, 2021. KALA Stock’s Forward Dividend of 0 and its yield of 0% are making investors’ thoughts stronger that it could fall further before the company announces its earnings for the current quarter. Investor Contact. Loraine Spreen. +1-857-277-4842.

Find real-time KALA - Kala Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business.

$7.57. +0.31 (+4.27%) DATA AS OF Apr 09, 2021. Add to Watchlist. 2021-04-16 2021-04-12 Kala Pharmaceuticals stock is trading at 6.87 as of the 12th of April 2021, a -9.25 percent decrease since the beginning of the trading day.

How has Kala Pharmaceuticals's share price performed over time and what events caused price changes? Latest Share Price and Events Stable Share Price : KALA is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 10% a week. Kala Pharmaceuticals market cap is $393.9 m.. View Kala Pharmaceuticals stock / share price, financial statements, key ratios and more at Craft. 2021-03-30 · Kala Pharmaceuticals, Inc. (NASDAQ:KALA)’s beta value is holding at 0.39, while the average true range (ATR) indicator is currently reading 0.61. Considering analysts have assigned the stock a price target range of $10-$49 as the low and high respectively, we find the trailing 12-month average consensus price target to be $20.71.